Binding of Natural Inhibitors to Respiratory Complex I

9Citations
Citations of this article
33Readers
Mendeley users who have this article in their library.

Abstract

NADH:ubiquinone oxidoreductase (respiratory complex I) is a redox-driven proton pump with a central role in mitochondrial oxidative phosphorylation. The ubiquinone reduction site of complex I is located in the matrix arm of this large protein complex and connected to the membrane via a tunnel. A variety of chemically diverse compounds are known to inhibit ubiquinone reduction by complex I. Rotenone, piericidin A, and annonaceous acetogenins are representatives of complex I inhibitors from biological sources. The structure of complex I is determined at high resolution, and inhibitor binding sites are described in detail. In this review, we summarize the state of knowledge of how natural inhibitors bind in the Q reduction site and the Q access pathway and how their inhibitory mechanisms compare with that of a synthetic anti-cancer agent.

Cite

CITATION STYLE

APA

Schiller, J., & Zickermann, V. (2022, September 1). Binding of Natural Inhibitors to Respiratory Complex I. Pharmaceuticals. MDPI. https://doi.org/10.3390/ph15091088

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free